Search results for " oligonucleotide"
Article
Future Downstream Process Development Solutions for Advanced Therapies
downstream
Click here to view more Industry Leader Q&As >>
Peter Guterstam, PhD, Product Manager of Next Generation Resins & Technologies at Cytiva, provides insight into solutions for ad…
Article
Gene Therapies Push Viral Vector Production
“Apart from plasmids there are liposomes, lipoplexes, polyplexes, and oligonucleotides [that can be used] as non-viral modes of gene delivery.”
Vicaire also notes that using non-viral vehicles …
Article
Biopharma Manufacturers Respond to Ebola Crisis
And Sarepta Therapeutics (Cambridge, MA) is looking to produce clinical supplies of its oligonucleotide (AVI 7537) for initial studies.
A promising treatment is favipiravir (T-705), an oral tablet…
Article
Q&As with Industry Leaders
Putrich, BioPharm International
John Scibetta, Advanced Chromatography Specialist, Cytiva
Q&A: Oligonucleotide Synthesis in Process Development and Scale-Up
Megan Manzano, BioPh…
Article
Quality by Design—Bridging the Gap between Concept and Implementation
The drive to embed quality-by-design (QbD) principles into the pharmaceutical regulatory framework of the European Union has reached a key point 10 years after the European Medicines Agency (EMA) firs…